Aberdeen, United Kingdom

Seanin McCluskey

This inventor holds 21 USPTO granted patents and 2 published patent applications, primarily in Bacterial Compositions. Top assignee: 4D Pharma Research Limited. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seanin McCluskey. Retrieved from https://idiyas.com/inventor/seanin-mccluskey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 76.2

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 205(Granted Patents)


Location History:

  • Aberdeen, GB (2017 - 2022)
  • Leeds, GB (2019 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Areas of Expertise:
Bacterial Strains
Biotechnology
Compositions
Microbial Applications
Strain Formulations
Biological Engineering
Pharmaceuticals
Food Technology
Agricultural Uses
Health Solutions
Environmental Applications
Genetic Engineering
21 patents (USPTO):Explore Patents

Title: Innovations of Seanin McCluskey: A Pioneer in Bacterial Strains

Introduction: Seanin McCluskey is a notable inventor based in Aberdeen, GB, recognized for his significant contributions to the field of medical innovations. With an impressive portfolio of 21 patents, he has dedicated his career to developing solutions aimed at treating and preventing inflammatory and autoimmune diseases.

Latest Patents: Among his latest innovations are compositions comprising bacterial strains. These inventions specifically focus on harnessing the potential of bacterial strains to address inflammatory and autoimmune conditions, showcasing a forward-thinking approach to modern medicine.

Career Highlights: Seanin McCluskey currently works at 4D Pharma Research Limited, where he utilizes his expertise to drive research and development in the field of therapeutic solutions. His innovative mindset and commitment to advancing medical knowledge have positioned him as a leading figure in his company and the broader scientific community.

Collaborations: Throughout his career, Seanin has collaborated with esteemed colleagues such as Imke Elisabeth Mulder and George Grant. These partnerships have fostered an environment of creativity and ingenuity, contributing to the success of their collective efforts in the biotechnology sector.

Conclusion: Seanin McCluskey's work exemplifies the impact that innovations in bacterial strains can have on healthcare. His commitment to developing effective treatments for inflammatory and autoimmune diseases continues to inspire fellow inventors and researchers alike. With each patent, McCluskey solidifies his legacy as a pioneer and innovator in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…